Cosmos Health Inc. (NASDAQ: COSM), is a fully reporting Pharmaceutical Holding Company incorporated in Chicago, Illinois, USA, that specializes, through its subsidiaries, in the wholesale of pharmaceutical products throughout Europe. The group offers its own lines of proprietary products, such as "Sky Premium Life" and "Mediterranation," as well as a broad range of branded generics and OTC medications. The group's subsidiaries in the EU and the UK serve retail pharmacies and wholesale distributors in the healthcare distribution sector.
Cosmos Health Inc. is focused on developing novel patented nutraceuticals and specialized root extracts, as well as proprietary complex generics and innovative OTC products through its R&D efforts.
Management's areas of focus include branded and generic pharmaceuticals, health products and food supplements, acquisitions, local and direct-to-pharmacy wholesale distribution as well as strategic research and development across each business unit with a particular focus on nutraceutical products with low-risk profiles and well-defined regulatory pathways. The company's strategic approach involves evaluating product availability, pricing, demand trends, and patent expirations to maximize performance, expanding its distribution reach, and vertically integrating into the supply chain for better prices and increased sales and profit margins.